U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process (Drugs)
  4. Development Resources
  5. Over-the-Counter (OTC) Drugs
  6. Status of OTC Rulemakings
  7. Rulemaking History for OTC Expectorant Drug Products
  1. Over-the-Counter (OTC) Drugs

Rulemaking History for OTC Expectorant Drug Products

Rulemaking History for OTC Expectorant Drug Products

Final Monograph(21 CFR part 341):
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use

FDA Archive-It webpage:

Search for Federal Register documents:

OTC Expectorant Drug Products found on this page:

Expectorant Drug Products: Original Active Ingredients and Labeling

Advance Notice Of Proposed RulemakingDateFR Citation
Advance Notice of Proposed Rulemaking9/9/197641FR38312disclaimer icon
   Reopening of Administrative Record3/21/198045FR18400disclaimer icon
   Reopening of Administrative Record9/26/198045FR63874disclaimer icon
Proposed RuleDateFR Citation
Tentative Final Monograph7/9/198247FR30002disclaimer icon
   Extension of Comment Period8/27/198247FR37934disclaimer icon
Final RuleDateFR Citation
Final Monograph2/28/198954FR8494disclaimer icon
   Correction3/22/198954FR11866disclaimer icon
   Technical Amendment: Replaces "sputum" with "mucus" in indication6/30/199257FR29176disclaimer icon
Final Rule: Classifies ipecac as nonmonograph9/14/199257FR41857disclaimer icon
   Correction10/6/199257FR46067disclaimer icon

Expectorant Drug Products: Combination Products

Proposed RuleDateFR Citation
Proposed Rule: Miscellaneous combinations8/12/198853FR30522disclaimer icon
   Clarification: Includes promethazine HCl combinations11/14/198853FR45774disclaimer icon
Notice: Prohibits OTC marketing of promethazine HCl combinations9/5/198954FR36762disclaimer icon
Reopening of Administrative Record: Promethazine HCl combinations11/28/198954FR48914disclaimer icon
   Correction1/4/199055FR310disclaimer icon
  Extension of Comment Period1/24/199055FR2387disclaimer icon
Proposed Rule: Bronchodilator, expectorant, and nasal decongestant combinations nonmonograph7/13/200570FR40232disclaimer icon

Expectorant Drug Products: Pediatric Use

Proposed RuleDateFR Citation
Notice: Advisory Committee Meeting8/16/200772FR46091disclaimer icon
Amendment of Notice: Advisory Committee Meeting10/1/200772FR55784disclaimer icon
Notice of Public Hearing: Request for comments8/25/200873FR50033disclaimer icon
Notice of Public Hearing: Correction9/2/200873FR51309disclaimer icon